Gland Pharma Limited (BOM:543245)
1,730.85
-38.95 (-2.20%)
At close: Dec 4, 2025
Gland Pharma Revenue
Gland Pharma had revenue of 14.87B INR in the quarter ending September 30, 2025, with 5.76% growth. This brings the company's revenue in the last twelve months to 58.01B, down -1.51% year-over-year. In the fiscal year ending March 31, 2025, Gland Pharma had annual revenue of 56.17B, down -0.85%.
Revenue (ttm)
58.01B
Revenue Growth
-1.51%
P/S Ratio
4.97
Revenue / Employee
13.33M
Employees
4,351
Market Cap
288.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 56.17B | -482.18M | -0.85% |
| Mar 31, 2024 | 56.65B | 20.40B | 56.29% |
| Mar 31, 2023 | 36.25B | -7.76B | -17.64% |
| Mar 31, 2022 | 44.01B | 9.38B | 27.08% |
| Mar 31, 2021 | 34.63B | 8.30B | 31.51% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |